+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Pneumoconiosis Global Market Report 2025 - Product Thumbnail Image

Pneumoconiosis Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
From
From
From
From
From
Bronchitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Bronchitis Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 566 Pages
  • Global
From
Cystic Fibrosis Devices - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Devices - Global Strategic Business Report

  • Report
  • November 2025
  • 93 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis - Global Strategic Business Report - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Global Strategic Business Report

  • Report
  • November 2025
  • 181 Pages
  • Global
From
Sleep Apnoea Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sleep Apnoea Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Refractory Cough - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Refractory Cough - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pulmonary Alveolar Proteinosis - Pipeline Insight, 2025 - Product Thumbnail Image

Pulmonary Alveolar Proteinosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 220 Pages
  • Global
From
Sleep Apnea - Pipeline Insight, 2025 - Product Thumbnail Image

Sleep Apnea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Nasal Polyposis - Pipeline Insight, 2025 - Product Thumbnail Image

Nasal Polyposis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Cystic Fibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more